Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.13 AUD | +0.85% | +1.13% | -7.16% |
Mar. 25 | Miners, healthcare firms push Australia stocks higher | RE |
Mar. 19 | Australia shares flat ahead of key RBA policy decision | RE |
Summary
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 11.86 for the current year.
- The company appears to be poorly valued given its net asset value.
- The company is one of the best yield companies with high dividend expectations.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- Based on current prices, the company has particularly high valuation levels.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commercial REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-7.16% | 5.05B | A+ | ||
-2.62% | 6.49B | C | ||
-9.25% | 4.84B | B- | ||
-1.87% | 4.16B | - | ||
+8.68% | 4B | B | ||
-14.61% | 3.99B | A- | ||
+15.67% | 3.39B | B+ | ||
-11.53% | 3.32B | B | ||
+0.30% | 3.1B | B | ||
+17.07% | 2.85B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DXS Stock
- Ratings DEXUS